Fat Grafting Technique for Fecal Incontinence

Status unconfirmed · Not applicable

Conditions studied: Fecal Incontinence

In brief

Fecal Incontinence affects an estimated 2-20% of the general population, and up to 50% of the elderly and institutionalized population. Patients with incontinence tend to suffer in silence; they often do not seek help because of embarrassment and stigma. They often become confined to their homes because they are afraid of having an "accident". Although this is not a life-threatening condition, the psychological, emotional, and social impact can be devastating.

Key facts

Study ID: NCT03882632
Run by: Melanie Salerno, RN
People needed: 10
Starts: 2019-04-11
Expected to finish: 2021-12-01
Last updated by the study team: 2020-07-09

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Age: >18 < 65 years
Sex: females
Affected by fecal incontinence (moderate to severe) independently from the etiology and previous treatments
No restrictions to follow-up for 24 months after treatment
Willing and able to provide informed consent

You may not qualify if…

Present diagnosis of cancer (not in remission)
Patients with uncorrected rectal prolapse
Overflow incontinence
Patients with neurogenic bowel or spinal cord injuries
Any patients unable to give informed consent, including members of vulnerable populations
Patients with concomitant pelvic floor disorders, like paradoxical puborectalis contraction or pelvic floor dysfunction
Chronic diarrhea
Patients with chronic steroid use
Patients 17 and under
Anal Sepsis (abscess and/or fistula)
Inability to undergo the intended diagnostic tests and follow-up
Pregnancy
Diagnosis of Diabetes Mellitus 1 and 2

Where it is running

Lifespan — Providence, Rhode Island, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.